ALEVIN THERAPEUTICS LIMITED

Active Cambridge

Other research and experimental development on natural sciences and engineering

0 employees website.com
Life sciences and medical technology Other research and experimental development on natural sciences and engineering
A

ALEVIN THERAPEUTICS LIMITED

Other research and experimental development on natural sciences and engineering

Founded 11 Mar 2022 Active Cambridge, England 0 employees website.com
Life sciences and medical technology Other research and experimental development on natural sciences and engineering
Accounts Submitted 22 Dec 2025 Next due 31 Dec 2026 8 months remaining
Confirmation Submitted 18 Mar 2026 Next due 24 Mar 2027 11 months remaining
Net assets £473K £233K 2023 year on year
Total assets £481K £289K 2023 year on year
Total Liabilities £8K £56K 2023 year on year
Charges None No charges registered

Contact & Details

Contact

Registered Address

Hauxton House, Mill Sci Tech Park Mill Lane Hauxton Cambridge CB22 5HX England

Email

info@example.com

Website

www.example.com

Full company profile for ALEVIN THERAPEUTICS LIMITED (13971892), an active life sciences and medical technology company based in Cambridge, England. Incorporated 11 Mar 2022. Other research and experimental development on natural sciences and engineering. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2023
Type Total Exemption Full
Next accounts 31 December 2024
Due by 30 September 2025 9 months

Net Assets, Total Assets & Total Liabilities (2022–2023)

Cash in Bank

N/A

Net Assets

£473.15k

Decreased by £233.45k (-33%)

Total Liabilities

£8.03k

Decreased by £55.85k (-87%)

Turnover

N/A

Employees

N/A

Debt Ratio

2%

Decreased by 6 (-75%)

Financial History

Revenue, profit, EBITDA and key financial figures

2023
Dec Year End
2022
Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

Funding Rounds 1

Investors (2)

Investor NameInvestor SinceParticipating Rounds
Investor 1Jul 2022Seed
Investor 2Jul 2022Seed

Share Capital

Share Capital

Share allotments and capital structure

4 Allotments 19,248 Shares £919k Total
Date FromShare ClassShares AllottedAmount RaisedPrice/Share
22 Jul 20229,272£619k£66.76
22 Jul 20222,247£150k£66.756
1 Apr 20222,728£150k£54.985
11 Mar 20225,001£0.5£0

Officers

Officers

3 active
Status
Macgowan, Alice Laura, DrDirectorBritishUnited Kingdom4920 Apr 2022Active
Mcinally, ThomasDirectorBritishEngland7011 Mar 2022Active
Shah, Sunil RajenDirectorBritishUnited Kingdom5220 Apr 2022Active

Shareholders

Shareholders (6)

O2h Nominees Limited (on Behalf Of O2h Ventures Limited)
49.5%
1,200,000
University Of Nottingham
29.9%
724,800

Persons with Significant Control

Persons with Significant Control (2)

2 Active 2 Ceased
Active
Notified 22 Jul 2022
Nature of Control
  • Ownership Of Shares 25 To 50 Percent,ownership Of Shares 25 To 50 Percent As Firm,voting Rights 25 To 50 Percent,voting Rights 25 To 50 Percent As Firm,right To Appoint And Remove Directors As Firm
Notified 22 Jul 2022
Nature of Control
  • Ownership Of Shares 25 To 50 Percent,ownership Of Shares 50 To 75 Percent As Firm,voting Rights 50 To 75 Percent,voting Rights 50 To 75 Percent As Firm,right To Appoint And Remove Directors As Firm

Simon John Fawcett Macdonald

Ceased 22 Jul 2022

Ceased

Thomas Mcinally

Ceased 22 Jul 2022

Ceased

Group Structure

Group Structure

BLOKKX LTD. united kingdom
ALEVIN THERAPEUTICS LIMITED Current Company

Charges

Charges

No charges registered

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
18 Mar 2026Confirmation StatementConfirmation statement made on 10 Mar 2026 with updates
22 Dec 2025AccountsAnnual accounts made up to 31 Mar 2025
12 Mar 2025Confirmation StatementConfirmation statement made on 10 Mar 2025 with updates
22 Jan 2025CapitalCapital Alter Shares Subdivision
22 Jan 2025ResolutionResolutions
18 Mar 2026 Confirmation Statement

Confirmation statement made on 10 Mar 2026 with updates

22 Dec 2025 Accounts

Annual accounts made up to 31 Mar 2025

12 Mar 2025 Confirmation Statement

Confirmation statement made on 10 Mar 2025 with updates

22 Jan 2025 Capital

Capital Alter Shares Subdivision

22 Jan 2025 Resolution

Resolutions

Recent Activity

Latest Activity

Confirmation statement made on 10 Mar 2026 with updates

1 months ago on 18 Mar 2026

Annual accounts made up to 31 Mar 2025

4 months ago on 22 Dec 2025

Confirmation statement made on 10 Mar 2025 with updates

1 years ago on 12 Mar 2025

Capital Alter Shares Subdivision

1 years ago on 22 Jan 2025

Resolutions

1 years ago on 22 Jan 2025